Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

New treatments and understanding of skin lupus are emerging in 2024.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Elderly people often have skin issues like wrinkles, dryness, and benign tumors, needing special dermatology care.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Oral pigmentation can be a sign of Addison's disease.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.